Khan M, Herle A, Movahed M
J Atr Fibrillation. 2017; 5(5):800.
PMID: 28496818
PMC: 5153113.
DOI: 10.4022/jafib.800.
Elefteriou F, Campbell P, Ma Y
Calcif Tissue Int. 2013; 94(1):140-51.
PMID: 23765388
PMC: 3883940.
DOI: 10.1007/s00223-013-9752-4.
Khan M, Wendel C, Movahed M
Ann Noninvasive Electrocardiol. 2013; 18(1):58-68.
PMID: 23347027
PMC: 6932325.
DOI: 10.1111/anec.12004.
Redelmeier D, Scales D, Kopp A
BMJ. 2005; 331(7522):932.
PMID: 16210252
PMC: 1261186.
DOI: 10.1136/bmj.38603.746944.3A.
Geleris P, Boudoulas H, Schaal S, Lewis R, Lima J
Eur J Clin Pharmacol. 1980; 18(4):311-4.
PMID: 7439250
DOI: 10.1007/BF00561387.
Usefulness of the systolic time intervals in cardiovascular clinical cardiology.
Lewis R, Boudoulas H, Leier C, Unverferth D, WEISSLER A
Trans Am Clin Climatol Assoc. 1981; 93:108-20.
PMID: 7345706
PMC: 2279551.
Sudden versus gradual withdrawal of sotalol in ambulant patients with ischaemic heart disease.
Henderson A, Errington J
Br Heart J. 1982; 48(6):552-4.
PMID: 7171401
PMC: 482747.
DOI: 10.1136/hrt.48.6.552.
Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.
Holford N, Sheiner L
Clin Pharmacokinet. 1981; 6(6):429-53.
PMID: 7032803
DOI: 10.2165/00003088-198106060-00002.
Drug withdrawal syndromes-- a literature review.
Hodding G, Jann M, ACKERMAN I
West J Med. 1980; 133(5):383-91.
PMID: 7008358
PMC: 1272349.
Adverse reactions to drugs.
Ross J
Br Med J (Clin Res Ed). 1981; 282(6270):1157.
PMID: 6786479
PMC: 1505094.
DOI: 10.1136/bmj.282.6270.1157-b.
Unchanged peripheral sympathetic activity following withdrawal of chronic metoprolol treatment. A study of noradrenaline concentrations and kinetics in plasma.
Olsson G, Daleskog M, Hjemdahl P, Rehnqvist N
Br J Clin Pharmacol. 1984; 18(4):573-9.
PMID: 6487497
PMC: 1463612.
DOI: 10.1111/j.1365-2125.1984.tb02506.x.
Comparison of changes in the characteristics of beta-adrenoceptors and responsiveness of human circulating lymphocytes during and after chronic administration of pindolol and propranolol.
Giudicelli Y, Lacasa D, Agli B, Leneveu A
Eur J Clin Pharmacol. 1984; 26(1):7-12.
PMID: 6325205
DOI: 10.1007/BF00546700.
Regulation of human leukocyte beta receptors by endogenous catecholamines: relationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol.
Fraser J, Nadeau J, Robertson D, Wood A
J Clin Invest. 1981; 67(6):1777-84.
PMID: 6263952
PMC: 370756.
DOI: 10.1172/jci110217.
Effect of propranolol on beta-adrenoceptors in rat hearts.
Baker S, Potter L
Br J Pharmacol. 1980; 68(1):8-10.
PMID: 6244034
PMC: 2044089.
DOI: 10.1111/j.1476-5381.1980.tb10689.x.
Hypertension in anaesthesia.
Reid D, Aylmer A
Can Anaesth Soc J. 1984; 31(2):222-31.
PMID: 6142758
DOI: 10.1007/BF03015265.
Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?.
McDevitt D
Drugs. 1983; 25(4):331-8.
PMID: 6133735
DOI: 10.2165/00003495-198325040-00001.
The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.
Prichard B, Walden R
Br J Clin Pharmacol. 1982; 13(Suppl 2):337S-343S.
PMID: 6125186
PMC: 1402177.
DOI: 10.1111/j.1365-2125.1982.tb01938.x.
Effect of abrupt withdrawal of chronically administered beta-blocking drugs on cardiac sensitivity in the rat.
BOTTING J, Crook P
Experientia. 1981; 37(12):1320-2.
PMID: 6120090
DOI: 10.1007/BF01948385.
Dissociation between duration of plasma catecholamine and blood pressure responses to beta-adrenergic blockade in normotensive subjects during physical exercise.
Planz G, Planz R
Eur J Clin Pharmacol. 1981; 19(2):83-8.
PMID: 6110540
DOI: 10.1007/BF00568393.
Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.
Aarons R, Nies A, Gal J, Hegstrand L, Molinoff P
J Clin Invest. 1980; 65(5):949-57.
PMID: 6102572
PMC: 371424.
DOI: 10.1172/JCI109781.